ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value ($000): $788,151 (100.0% shares, 0.0% debt)

Holdings (19)

— QUIDEL CORP 51.6%

Value ($000) $406,333 Shares 1,816,094 Est. Cost $24542.18 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 18.7%

Value ($000) $147,075 Shares 2,011,700 Est. Cost $49.05 Unrealized —

— ACCELERATE DIAGNOSTICS INC 7.8%

Value ($000) $61,685 Shares 4,068,942 Est. Cost $22.26 Unrealized —

OPK OPKO HEALTH INC 5.2%

Value ($000) $41,076 Shares 12,045,886 Est. Cost $3.37 Unrealized -33.6%

— ASPIRA WOMENS HEALTH INC 5.0%

Value ($000) $39,508 Shares 10,288,587 Est. Cost $3.84 Unrealized —

— AGENUS INC 3.4%

Value ($000) $26,419 Shares 6,722,460 Est. Cost $2.96 Unrealized —

— AMARIN CORP PLC 1.9%

Value ($000) $15,004 Shares 2,168,142 Est. Cost $494.19 Unrealized —

— QUIDEL CORP 1.5%

Value ($000) $12,037 Shares 191,300 Est. Cost $24542.18 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 1.2%

Value ($000) $9,530 Shares 2,000,000 Est. Cost $3.99 Unrealized 0.0%

— SOLENO THERAPEUTICS INC 1.0%

Value ($000) $8,148 Shares 3,670,384 Est. Cost $1.78 Unrealized —

— MOTUS GI HLDGS INC 0.6%

Value ($000) $5,028 Shares 3,806,666 Est. Cost $3.08 Unrealized —

— ANTARES PHARMA INC 0.6%

Value ($000) $4,674 Shares 1,699,566 Est. Cost $3.19 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 0.6%

Value ($000) $4,555 Shares 1,320,359 Est. Cost $4.67 Unrealized -27.1%

— BIOHAVEN PHARMACTL HLDG CO L 0.3%

Value ($000) $2,494 Shares 63,100 Est. Cost $49.05 Unrealized —

— Y-MABS THERAPEUTICS INC 0.1%

Value ($000) $1,089 Shares 25,212 Est. Cost $26.10 Unrealized —

— BIOLASE INC 0.1%

Value ($000) $1,000 Shares 1,739,100 Est. Cost $1.21 Unrealized —

BIIB BIOGEN INC 0.1%

Value ($000) $987 Shares 3,688 Est. Cost $213.68 Unrealized +40.7%

— CONTRAFECT CORP 0.1%

Value ($000) $823 Shares 128,845 Est. Cost $5.76 Unrealized —

— ACCELERATE DIAGNOSTICS INC 0.1%

Value ($000) $686 Shares 137,900 Est. Cost $22.26 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	QUIDEL CORP	1,816,094	$406,333	51.6%	$24542.18	—	COM	74838J101
—	BIOHAVEN PHARMACTL HLDG CO L	2,011,700	$147,075	18.7%	$49.05	—	COM	G11196105
—	ACCELERATE DIAGNOSTICS INC	4,068,942	$61,685	7.8%	$22.26	—	COM	00430H102
OPK	OPKO HEALTH INC	12,045,886	$41,076	5.2%	$3.37	-33.6%	COM	68375N103
—	ASPIRA WOMENS HEALTH INC	10,288,587	$39,508	5.0%	$3.84	—	COM	04537Y109
—	AGENUS INC	6,722,460	$26,419	3.4%	$2.96	—	COM NEW	00847G705
—	AMARIN CORP PLC	2,168,142	$15,004	1.9%	$494.19	—	SPONS ADR NEW	023111206
—	QUIDEL CORP	191,300	$12,037	1.5%	$24542.18	—	Call	74838J101
BCRX	BIOCRYST PHARMACEUTICALS INC	2,000,000	$9,530	1.2%	$3.99	0.0%	COM	09058V103
—	SOLENO THERAPEUTICS INC	3,670,384	$8,148	1.0%	$1.78	—	COM NEW	834203200
—	MOTUS GI HLDGS INC	3,806,666	$5,028	0.6%	$3.08	—	COM	62014P108
—	ANTARES PHARMA INC	1,699,566	$4,674	0.6%	$3.19	—	COM	036642106
PACB	PACIFIC BIOSCIENCES CALIF IN	1,320,359	$4,555	0.6%	$4.67	-27.1%	COM	69404D108
—	BIOHAVEN PHARMACTL HLDG CO L	63,100	$2,494	0.3%	$49.05	—	Call	G11196105
—	Y-MABS THERAPEUTICS INC	25,212	$1,089	0.1%	$26.10	—	COM	984241109
—	BIOLASE INC	1,739,100	$1,000	0.1%	$1.21	—	COM NEW	090911207
BIIB	BIOGEN INC	3,688	$987	0.1%	$213.68	+40.7%	COM	09062X103
—	CONTRAFECT CORP	128,845	$823	0.1%	$5.76	—	COM NEW	212326300
—	ACCELERATE DIAGNOSTICS INC	137,900	$686	0.1%	$22.26	—	Call	00430H102